Stoke Therapeutics (STOK) Other Accumulated Expenses: 2022-2025
Historic Other Accumulated Expenses for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $795,000.
- Stoke Therapeutics' Other Accumulated Expenses rose 33.17% to $795,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $795,000, marking a year-over-year increase of 33.17%. This contributed to the annual value of $753,000 for FY2024, which is 12.14% down from last year.
- Per Stoke Therapeutics' latest filing, its Other Accumulated Expenses stood at $795,000 for Q3 2025, which was down 54.57% from $1.8 million recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Other Accumulated Expenses peaked at $2.1 million during Q1 2025, and registered a low of $426,000 during Q3 2022.
- Its 3-year average for Other Accumulated Expenses is $956,727, with a median of $795,000 in 2025.
- Its Other Accumulated Expenses has fluctuated over the past 5 years, first decreased by 12.14% in 2024, then spiked by 111.63% in 2025.
- Quarterly analysis of 4 years shows Stoke Therapeutics' Other Accumulated Expenses stood at $509,000 in 2022, then spiked by 68.37% to $857,000 in 2023, then decreased by 12.14% to $753,000 in 2024, then soared by 33.17% to $795,000 in 2025.
- Its Other Accumulated Expenses was $795,000 in Q3 2025, compared to $1.8 million in Q2 2025 and $2.1 million in Q1 2025.